Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SELECT-LIFE (SELECT Follow-up Study to Evaluate Long-term Impact oF Anti-obEsity Medication)

NCT04972721 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04972721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04972721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SELECT-LIFE (SELECT Follow-up Study to Evaluate Long-term Impact oF Anti-obEsity Medication)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
September 1, 2023
Completion date
August 25, 2025
Enrollment
3,439 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight